StockData
Cogent Biosciences, Inc. logo

Cogent Biosciences, Inc. (COGT) stock

COGTNasdaqPharmaceutical PreparationsFiscal year ends December 31
Financials through Q2 FY2026, quarter ended Jun 30, 2026Last filing: 10-Q on Nov 5, 2026Score 2/30
$27.85+0.41 (+1.49%)

Close on Nov 17, 2026Market cap $4.83BP/E –Yield –

Earnings

Cogent Biosciences's quarterly results as reported in its earnings releases, with the company's own outlook. Hover a number to see the sentence it came from.

Next report
Feb 16, 2027
Q4 FY2026 · estimated, before the open
Revenue, Q2 FY2024
–
EPS, Q2 FY2024
-$0.59
-$0.59 a year earlier
Latest guidance
None
No outlook given in releases

Quarterly results

Revenue and earnings per share from each of Cogent Biosciences's earnings releases, newest first

QuarterReportedRevenueYoYEPSSource
Q4 FY2026ended Dec 31, 2026Feb 16, 2027Expected––––
Q3 FY2026ended Sep 30, 2026Nov 5, 2026after the close–––Release
Q2 FY2026ended Jun 30, 2026Aug 10, 2026before the open–––Release
Q1 FY2026ended Mar 31, 2026May 5, 2026before the open–––Release
Q4 FY2025ended Dec 31, 2025Feb 17, 2026before the open–––Release
Q3 FY2025ended Sep 30, 2025Nov 3, 2025before the open–––Release
Q2 FY2025ended Jun 30, 2025Jul 10, 2025before the open–––Release
Q1 FY2025ended Mar 31, 2025May 6, 2025before the open–––Release
Q4 FY2024ended Dec 31, 2024Feb 25, 2025before the open–––Release
Q3 FY2024ended Sep 30, 2024Nov 12, 2024before the open–––Release
Q2 FY2024ended Jun 30, 2024Aug 6, 2024before the open––-$0.59Release
Q1 FY2024ended Mar 31, 2024May 7, 2024before the open––-$0.62Release

Figures as first announced; later restatements appear under Financials. Expected dates are estimated from the company's past reporting pattern.

Guidance

Cogent Biosciences has not given guidance in its releases

Many companies give their outlook only on the conference call or not at all. When Cogent Biosciences puts a forecast in an earnings release, it is listed here with the exact sentence.

Press releases

Releases Cogent Biosciences filed with the SEC as exhibits to Form 8-K or 6-K

  1. Results
  2. Results
  3. Results
  4. Results
  5. News
  6. Update
  7. Results
  8. Results
  9. Results
  10. Update
  11. Update
  12. Results
  13. Results
  14. Results
  15. News

See a number that looks wrong?